Issue 26, 2017

Novel hypoxia-targeting Pt(iv) prodrugs

Abstract

Novel Pt(IV) prodrugs targeting hypoxia inducible factor HIF-1α were prepared for evaluating their antitumor activity on hypoxic cancer cells for the first time. The resulting Pt(IV) prodrug exhibited effective inhibition on tumor growth in the HCT-116 xenograft mouse model with low toxicity in vivo.

Graphical abstract: Novel hypoxia-targeting Pt(iv) prodrugs

Supplementary files

Article information

Article type
Communication
Submitted
19 Feb 2017
Accepted
08 Mar 2017
First published
08 Mar 2017

Chem. Commun., 2017,53, 3749-3752

Novel hypoxia-targeting Pt(IV) prodrugs

Z. Xu, J. Zhao, S. Gou and G. Xu, Chem. Commun., 2017, 53, 3749 DOI: 10.1039/C7CC01320E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements